-
EP4213857
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4213857
| EP4213857 - THERAPEUTIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USE THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 23.06.2023 Database last updated on 06.07.2024 | |
| Former | The international publication has been made Status updated on 26.03.2022 | Most recent event Tooltip | 24.11.2023 | Change: Validation states | published on 27.12.2023 [2023/52] | 24.11.2023 | Change - extension states | published on 27.12.2023 [2023/52] | Applicant(s) | For all designated states Exithera Pharmaceuticals Inc. 1900 West Park Drive Suite 280 Westborough, MA 01581 / US | [2023/30] | Inventor(s) | 01 /
HAYWARD, Neil, J. Westborough, Massachusetts 01581 / US | 02 /
POLLACK, Charles, V., Jr. Westborough, Massachusetts 01581 / US | 03 /
KURZ, Michael, A. Westborough, Massachusetts 01581 / US | [2023/30] | Representative(s) | Harris, Jennifer Lucy, et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB | [2023/30] | Application number, filing date | 21870199.3 | 16.09.2021 | [2023/30] | WO2021US50623 | Priority number, date | US202063079742P | 17.09.2020 Original published format: US 202063079742 P | US202063079746P | 17.09.2020 Original published format: US 202063079746 P | [2023/30] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022060952 | Date: | 24.03.2022 | Language: | EN | [2022/12] | Type: | A1 Application with search report | No.: | EP4213857 | Date: | 26.07.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.03.2022 takes the place of the publication of the European patent application. | [2023/30] | Search report(s) | International search report - published on: | US | 24.03.2022 | Classification | IPC: | A61K31/7056, A61K31/706 | [2023/30] | CPC: |
A61K31/4427 (EP,IL,KR,US);
A61K45/06 (EP,IL,US);
A61K9/0019 (EP,IL,US);
A61P11/00 (KR);
A61P31/00 (EP,IL);
A61P31/12 (KR);
| C-Set: |
A61K31/4427, A61K2300/00 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/30] | Title | German: | THERAPEUTISCHE VERBINDUNGEN, ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG DAVON | [2023/30] | English: | THERAPEUTIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USE THEREOF | [2023/30] | French: | COMPOSÉS THÉRAPEUTIQUES, COMPOSITIONS ET LEURS PROCÉDÉS D'UTILISATION | [2023/30] | Entry into regional phase | 21.03.2023 | National basic fee paid | 21.03.2023 | Search fee paid | 21.03.2023 | Designation fee(s) paid | 21.03.2023 | Examination fee paid | Examination procedure | 21.03.2023 | Examination requested [2023/30] | 03.11.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 27.09.2023 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO2015120062 (EXITHERA PHARMACEUTICALS INC [US]) [Y] 1-7 * , especially: pg 16, bottom, first formula; pg 57, para 7; pg 58, para 2; pg 59, para 1; pg 94, para 3. *; | [Y] - Aleksandra Milewska; Falkowski Katherine; Kalinska Magdalena; Bielecka Ewa; Naskalska Antonina; Mak Pawel; Lesner Adam; Ochman Marek; Urlik Maciej; Potempa Jan; Kantyka Tomasz; Pyrc Krzysztof, "Kallikrein 13: a new player in coronaviral Infections", bioRxiv, (20200302), pages 1 - 45, XP055759813 [Y] 1-7 * , especially: abstract; pg 5, para 3. * DOI: http://dx.doi.org/10.1101/2020.03.01.971499 | [A] - Magnen Melia, Gueugnon Fabien, Petit-Courty Agnès, Baranek Thomas, Sizaret Damien, Brewah Yambasu A, Humbles Alison A, Si-Tahar Mustapha, Courty Yves, "Tissue kallikrein (KLK1) regulates alveolar macrophage apoptosis early in influenza 3 virus infection", American Journal of Physiology-Lung Cellular and Molecular Physiology, (20190000), vol. 316, no. 6, pages 1 - 41, XP055919431 [A] 1-7 * , entire document. * |